期刊文献+

乳腺癌干细胞与乳腺癌 被引量:1

在线阅读 下载PDF
导出
摘要 乳腺癌在女性肿瘤相关性疾病的死亡中占有主要地位,然而,其确切发病原因至今尚未完全明确,给乳腺癌的预防、早期诊断、恰当而合理的治疗带来了困难。乳腺癌干细胞在乳腺癌的发生、发展、治疗抵抗性、转移及复发中起到了关键作用。就乳腺癌干细胞的研究进展及其在乳腺癌治疗中的意义作一综述。
出处 《中国现代普通外科进展》 CAS 2009年第7期608-610,619,共4页 Chinese Journal of Current Advances in General Surgery
基金 卫生部科研基金项目(WKJ2007-3-001)
  • 相关文献

参考文献22

  • 1Bonnet D, Dick JE. Human acute myeloid leukenfia is organized as a hierarchy that originates from a primitive hematopoietic cell [j]. Nat Med, 1997,3(7):730-737.
  • 2Clarke J, Lodie TA, Blickarz CE, et al. Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem ceils reveals a lack of distinction [J]. Tissue Eng, 2002,8 (5): 739-751.
  • 3Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci USA, 2003,100(7):3983-3988.
  • 4Gabriella H, Par-Ola B, Markus R, et al. The CD44^+/CD24^- phenotype is enriched in basal-like breast tumors[R]. Breast Cancer Res, 2008,10(3):R53.
  • 5Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem progenitor cells[J]. Genes Dev, 2003,17(10):1253-1270.
  • 6Matthew JG, Lucienne C, Konstantinos P, et al. Mammosphere culture of metastatic breast cancer ceils enriches for tumorigenic breast cancer cells[R]. Breast Cancer Res, 200830(3):R52.
  • 7Zhou JB, Wulfkuhle J, Zhang H, et al. Activation of the PTEN/ mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance [J]. Proc Natl Acad Sci USA, 2007,104(41 ):16158-16163.
  • 8Li HZ, Yi TB, Wu ZY. Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells[J]. BMC Cancer, 2008,8:135.
  • 9Sheridan C, Kishimoto H, Fuchs RK, et al. CD44^+/CD24^- breast cancer cells exhihit enhanced invasive properties: an early step necessry formetastasis[R]. Breast Cancer Res, 2006,8 (5):R59.
  • 10Balic M, Young L. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype [J]. Clin Cancer Res, 2006,12 (19): 5615-5621.

二级参考文献8

  • 1[1]TANNISHTHA R,SEAN J M,MICHAEL F C,et al.Stem cells,cancer,and cancer stem cells[J].Nature,2001,414:105-111.
  • 2[2]AL-HAJJ M,WICHA M S,BENITO H A,et al.Prospective identification of tumorigenic breast cancer cells[J].Proc Nat Acad Sci USA,2003,100:3983-3988.
  • 3[3]KONDO T,SETOGUCHI T,TAGA T.Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line[J].Proc Natl Acad Sci USA,2004,101:781-786.
  • 4[4]MICHAEL D,TITO F,SUSAN B.Tumor stem cells and drug resistance[J].Nature Rev,2005,5:275-284.
  • 5[5]PAWITAN Y,BJOHLE J,AMLER L,et al.Gene expression profiling spares early breast cancer patients from adjuvant therapy:derived and validated in two population-based cohorts[J].Breast Cancer Res,2005,7:R953-R964.
  • 6[6]CHENG F,DANIEL S O,LODEWYK W,et al.Concordance among gene-expression based predictors for breast cancer[R].N Engl J Med,2006,355:560-569.
  • 7[7]LEONARD G D,FOJO T,BATES S E.The role of ABC transporters in clinical practice[J].Oncologist,2003,8:411-424.
  • 8[8]BEACHY P A,KARHADKAR S S,BERMAN D M.Tissue repair and stem cell renewal in carcinogenesis[J].Natuer,2004,432:324-331.

共引文献3

同被引文献41

  • 1Jordan CT,Guzman ML,Noble M. Cancer stem cells[J]. N Engl J Med,2006,355(12) :1253-1261.
  • 2Eyler CE,Rich JN. Survival of the fittest :cancer stem cells in thera- peutic resistance and angiogenesis[J]. J Clin Oncol, 2008,26 (17) 2839-2845.
  • 3Merlo LM,Pepper JW, Reid BJ, et aI. Cancer as an evolutionary and ecological process [J]. Nat Rev Cancer, 2006,6 (12) : 924- 935.
  • 4Al-Hajj M,Wicha MS,Benito-Hernandez A,et al. Prospective i- dentification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci U S A,2003,100(7):3983-3988.
  • 5Abbott A. Cancer:the root of the problem[J]. Nature, 2006,442 (7104) :742-743.
  • 6Fillmore CM,Kuperwasser C. Human breast cancer cell lines contain stem-like cells tb.at self-renew, give rise to pb.enotypically diverse progeny and survive chemotherapy[J]. Breast Cancer Res, 2008,10 (2):R25.
  • 7Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumori- genic breast cancer cells to chemotherapy[J]. J Natl Cancer Inst, 2008,100(9) : 672-679.
  • 8Sheridan C, Kishimoto H, Fuchs RK, et al. CD44+/CD24-- breast cancer cells exhibit enhanced invasive properties: an early step neces- sary for metastasis[J]. Breast Cancer Res, 2006,8 (5) : R59.
  • 9Balic M, Lin H, Young L, et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype[J]. Clin Cancer Res, 2006,12(19) :5615-5621.
  • 10Abraham BK,Fritz P,McClellan M,et al. Prevalence of CD44+/ CD24-/low cells in breast cancer may not be associated with clinical outcome hut may favor distant metastasis[J]. Clin Cancer Res,2005,11(3) : 1154-1159.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部